维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="Risitano AM"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Achievements and limita- tions of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria:the role of complement component 3 显示文摘	Risitano AM Perna F Selleri C	2011	Mini Rev Med Chem2011，11，6：	1
2	Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)显示文摘	Santarone S Bacigalupo A Risitano AM	2010	Hematologica2010，95，6：	1
3	Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria:long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)显示文摘	Santarone S Bacigalupo A Risitano AM		0，，06：	1
4	Aplastic anemia: management of adult patients 显示文摘	Maciejewski JP Risitano AM	2005	Hematology Am Soc Hematol Educ Program2005，，：	1
5	Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria 显示文摘	Risitano AM Ricklin D Huang Y	2014	Blood2014，123，13：	1
6	In-vivo dominant immune responses in aplastic anemia patients:molecular tracking of putatively pathogenic T cell clones by TCRβ-CDR3 sequencing 显示文摘	Risitano AM Maciejewski JP Green S	2004	Lancet2004，364，9431：	1
7	Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA显示文摘	Risitano AM Selleri C Serio B	2010	Br J Haematol2010，148，5：	1
8	Paroxysmal nocturnal hemog, Iobinuria and the compleme: system: recent insights and novel anticomplemat stratogies 显示文摘	Risitano AM	2013	Adv Exp Med Biol2013，735，：	1
9	Activated platelets of patients with paroxysmal nocturnal hemoglobinuria express cellular prion protein显示文摘	Holada K simak J Risitano AM et at	2002	Blood2002，100，3：	1
10	Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria显示文摘	Simak J Holada K Risitano AM	2004	Br J Haematol2004，125，6：	1
11	Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal haemoglobinuria measured by V-beta CDR3 spectratyping and flow cytometry显示文摘	Risitano AM Kook H Zeng W	2002	Blood2002，100，1：	1
12	Immunosuppressive therapies in the management of immune-mediated marrow failures in adults:where we stand and where we are going显示文摘	Risitano AM	2011	Br J Haematol2011，152，2：	1
13	Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single- lineage marrow failure: a pilot study and a survey from the EBMT WPSAA显示文摘	Risitano AM Selleri C Serio B	2010	Br J Haematol2010，148，5：	1
14	Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates:Campath (Alemtuzumab)显示文摘	Risitano AM Schrezenmeier H	2013	Bone Marrow Transplantation2013，48，2：	1
15	Paroxysmal nocturnal hemoglobinuria - hemolysis before and after eculizumab显示文摘	Risitano AM Notaro R Luzzatto L	2010	N Engl J Med2010，363，23：	1
16	Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria:long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo(GITMO)显示文摘	Santarone S Bacigalupo A Risitano AM	2010	Haematologica2010，95，6：	1
17	Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry显示文摘	Risitano AM Kook H Zeng W	2002	Blood2002，100，1：	1
18	Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry显示文摘	Risitano AM Kook H Zeng W	2002	Blood2002，100，1：	1
19	Polymorphism of the complement receptor 1 gene correlateswith the hematologic response to eculizumab in patients withparoxysmal nocturnal hemoglobinuria显示文摘	RondelliT AM Risitano R Peffault de Latour	2014	Haematologica2014，99，：	1
20	Safety and pharmacokinetics of the complement inhibitor TT30 in a phase I trial for untreated PNH patients 显示文摘	Risitano AM Storek M Sahelijo L	2015	Blood2015，126，23：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示